Chinese Journal of Chromatography ›› 2023, Vol. 41 ›› Issue (4): 348-358.DOI: 10.3724/SP.J.1123.2022.07007
• Articles • Previous Articles Next Articles
CHEN Jia, LIU Yulong, XU Bin, LIU Qin*(), XIE Jianwei
Received:
2022-07-12
Online:
2023-04-08
Published:
2023-04-03
Supported by:
CLC Number:
CHEN Jia, LIU Yulong, XU Bin, LIU Qin, XIE Jianwei. Rapid screening of Chemical Weapons Convention-related chemicals in oil matrix by headspace solid-phase microextraction and gas chromatography-mass spectrometry[J]. Chinese Journal of Chromatography, 2023, 41(4): 348-358.
Group | No. | Compound | Structure | CWC schedule | ||||
---|---|---|---|---|---|---|---|---|
Ⅰ | 1 | pinacolyl alcohol (片呐醇) | | 2.B.14 | ||||
2 | chloropicrin (氯化苦) | | 3.A.04 | |||||
3 | dimethyl phosphite (DMP) (亚膦酸二甲酯) | | 3.B.10 | |||||
4 | sarin (GB) (沙林) | | 1.A.01 | |||||
5 | 1,4-oxathiane (1,4-噻烷) | | N.S.* | |||||
6 | diethyl methylphosphonate (DEMP) (甲基膦酸二乙酯) | | 2.B.04 | |||||
Group | No. | Compound | Structure | CWC schedule | ||||
7 | 1,4-dithiane (1,4-二噻烷) | | N.S.* | |||||
8 | sulfur mustard (SM) (芥子气) | | 1.A.04 | |||||
9 | cyclopentyl methyl methylphosphonate (CPMMP) (甲基膦酸甲基环戊基酯) | | 2.B.04 | |||||
10 | 2-methyl-1,3,2-dithiaphosphinane 2-sulfide (2-甲基-1,3,2-二硫代膦-2-硫化物) | | 2.B.04 | |||||
Ⅱ | 11 | N-ethyl N-methylaminoethanol (EMAE) (甲基乙基乙醇胺) | | 2.B.11 | ||||
12 | N-methyl N-propylaminoethanol (MPAE) (甲基丙基乙醇胺) | | 2.B.11 | |||||
13 | methyldiethanolamine (MDEA) (甲基二乙醇胺) | | 3.B.15 | |||||
14 | ethyldiethanolamine (EDEA) (乙基二乙醇胺) | | 3.B.15 | |||||
15 | triethanolamine (TEA) (三乙醇胺) | | 3.B.17 | |||||
16 | thiodiglycol (TDG) (硫二苷醇) | | 2.B.13 | |||||
17 | quinuclidin-3-ol(喹咛醇) | | 2.B.09 | |||||
Ⅲ | 18 | methylphosphonic acid (MPA) (甲基膦酸) | | 2.B.04 | ||||
19 | ethyl methylphosphonic acid (EMPA) (乙基甲基膦酸) | | 2.B.04 | |||||
20 | isopropyl methylphosphonic acid (IMPA) (异丙基甲基膦酸) | | 2.B.04 | |||||
21 | isobutyl methylphosphonic acid (i-BuMPA) (异丁基甲基膦酸) | | 2.B.04 | |||||
22 | pinacolyl methylphosphonic acid (PMPA) (片呐基甲基膦酸) | | 2.B.04 | |||||
23 | cyclohexyl methylphosphonic acid (CHMPA) (环己基甲基膦酸) | | 2.B.04 | |||||
24 | 2,2-diphenyl-2-hydroxyacetic acid (BZA) (二苯羟乙酸) | | 2.B.08 |
Table 1 Selected Chemical Weapons Convention (CWC) related chemicals
Group | No. | Compound | Structure | CWC schedule | ||||
---|---|---|---|---|---|---|---|---|
Ⅰ | 1 | pinacolyl alcohol (片呐醇) | | 2.B.14 | ||||
2 | chloropicrin (氯化苦) | | 3.A.04 | |||||
3 | dimethyl phosphite (DMP) (亚膦酸二甲酯) | | 3.B.10 | |||||
4 | sarin (GB) (沙林) | | 1.A.01 | |||||
5 | 1,4-oxathiane (1,4-噻烷) | | N.S.* | |||||
6 | diethyl methylphosphonate (DEMP) (甲基膦酸二乙酯) | | 2.B.04 | |||||
Group | No. | Compound | Structure | CWC schedule | ||||
7 | 1,4-dithiane (1,4-二噻烷) | | N.S.* | |||||
8 | sulfur mustard (SM) (芥子气) | | 1.A.04 | |||||
9 | cyclopentyl methyl methylphosphonate (CPMMP) (甲基膦酸甲基环戊基酯) | | 2.B.04 | |||||
10 | 2-methyl-1,3,2-dithiaphosphinane 2-sulfide (2-甲基-1,3,2-二硫代膦-2-硫化物) | | 2.B.04 | |||||
Ⅱ | 11 | N-ethyl N-methylaminoethanol (EMAE) (甲基乙基乙醇胺) | | 2.B.11 | ||||
12 | N-methyl N-propylaminoethanol (MPAE) (甲基丙基乙醇胺) | | 2.B.11 | |||||
13 | methyldiethanolamine (MDEA) (甲基二乙醇胺) | | 3.B.15 | |||||
14 | ethyldiethanolamine (EDEA) (乙基二乙醇胺) | | 3.B.15 | |||||
15 | triethanolamine (TEA) (三乙醇胺) | | 3.B.17 | |||||
16 | thiodiglycol (TDG) (硫二苷醇) | | 2.B.13 | |||||
17 | quinuclidin-3-ol(喹咛醇) | | 2.B.09 | |||||
Ⅲ | 18 | methylphosphonic acid (MPA) (甲基膦酸) | | 2.B.04 | ||||
19 | ethyl methylphosphonic acid (EMPA) (乙基甲基膦酸) | | 2.B.04 | |||||
20 | isopropyl methylphosphonic acid (IMPA) (异丙基甲基膦酸) | | 2.B.04 | |||||
21 | isobutyl methylphosphonic acid (i-BuMPA) (异丁基甲基膦酸) | | 2.B.04 | |||||
22 | pinacolyl methylphosphonic acid (PMPA) (片呐基甲基膦酸) | | 2.B.04 | |||||
23 | cyclohexyl methylphosphonic acid (CHMPA) (环己基甲基膦酸) | | 2.B.04 | |||||
24 | 2,2-diphenyl-2-hydroxyacetic acid (BZA) (二苯羟乙酸) | | 2.B.08 |
Compound | tR/ min | Extracted ion (m/z) | LOD*/ (ng/mL) | RSD**/ % |
---|---|---|---|---|
Pinacolyl alcohol | 4.61 | 57 | 5 | 4.3 |
Chloropicrin | 5.46 | 117 | 100 | 11.6 |
Dimethyl phosphite | 5.90 | 80 | 30 | 8.4 |
Sarin | 6.14 | 99 | 1 | 3.9 |
1,4-Oxathiane | 7.13 | 104 | 2 | 4.2 |
Diethyl | 8.77 | 97 | 0.5 | 1.7 |
methylphosphonate | ||||
1,4-Dithiane | 9.52 | 120 | 1 | 3.3 |
Sulfur mustard | 10.68 | 109 | 1 | 4.5 |
Cyclopentyl methyl | 11.60 | 111 | 0.5 | 2.8 |
methylphosphonate | ||||
2-Methyl-1,3,2-dithia- | 15.28 | 184 | 30 | 7.7 |
phosphinane 2-sulfide |
Table 2 Limits of detection (LODs) and precisions of HS-SPME and GC-MS analysis (n=6)
Compound | tR/ min | Extracted ion (m/z) | LOD*/ (ng/mL) | RSD**/ % |
---|---|---|---|---|
Pinacolyl alcohol | 4.61 | 57 | 5 | 4.3 |
Chloropicrin | 5.46 | 117 | 100 | 11.6 |
Dimethyl phosphite | 5.90 | 80 | 30 | 8.4 |
Sarin | 6.14 | 99 | 1 | 3.9 |
1,4-Oxathiane | 7.13 | 104 | 2 | 4.2 |
Diethyl | 8.77 | 97 | 0.5 | 1.7 |
methylphosphonate | ||||
1,4-Dithiane | 9.52 | 120 | 1 | 3.3 |
Sulfur mustard | 10.68 | 109 | 1 | 4.5 |
Cyclopentyl methyl | 11.60 | 111 | 0.5 | 2.8 |
methylphosphonate | ||||
2-Methyl-1,3,2-dithia- | 15.28 | 184 | 30 | 7.7 |
phosphinane 2-sulfide |
Compound | tR/ min | Extracted ion (m/z) | LOD*/ (ng/mL) | RSD**/ % |
---|---|---|---|---|
EMAE (TMS) | 8.14 | 72 | 50 | 8.5 |
MPAE (TMS) | 9.06 | 86 | 50 | 7.3 |
MDEA (2TMS) | 11.66 | 160 | 30 | 6.8 |
EDEA (2TMS) | 12.13 | 174 | 30 | 3.9 |
TEA (3TMS) | 14.45 | 262 | 100 | 10.7 |
TDG (2TMS) | 12.70 | 116 | 20 | 8.3 |
Quinuclidin-3-ol (TMS) | 11.28 | 200 | 20 | 14.3 |
MPA (2TMS) | 10.04 | 225 | 50 | 6.7 |
EMPA (TMS) | 9.34 | 153 | 20 | 4.6 |
IMPA (TMS) | 9.64 | 153 | 20 | 5.9 |
i-BuMPA (TMS) | 10.78 | 153 | 30 | 9.6 |
PMPA (TMS) | 11.73 | 153 | 50 | 11.2 |
CHMPA (TMS) | 13.27 | 153 | 50 | 8.8 |
BZA (2TMS) | 16.47 | 255 | 300 | 19.4 |
Table 3 LODs and precisions of HS-SPME and GC-MS analysis after derivatization (n=6)
Compound | tR/ min | Extracted ion (m/z) | LOD*/ (ng/mL) | RSD**/ % |
---|---|---|---|---|
EMAE (TMS) | 8.14 | 72 | 50 | 8.5 |
MPAE (TMS) | 9.06 | 86 | 50 | 7.3 |
MDEA (2TMS) | 11.66 | 160 | 30 | 6.8 |
EDEA (2TMS) | 12.13 | 174 | 30 | 3.9 |
TEA (3TMS) | 14.45 | 262 | 100 | 10.7 |
TDG (2TMS) | 12.70 | 116 | 20 | 8.3 |
Quinuclidin-3-ol (TMS) | 11.28 | 200 | 20 | 14.3 |
MPA (2TMS) | 10.04 | 225 | 50 | 6.7 |
EMPA (TMS) | 9.34 | 153 | 20 | 4.6 |
IMPA (TMS) | 9.64 | 153 | 20 | 5.9 |
i-BuMPA (TMS) | 10.78 | 153 | 30 | 9.6 |
PMPA (TMS) | 11.73 | 153 | 50 | 11.2 |
CHMPA (TMS) | 13.27 | 153 | 50 | 8.8 |
BZA (2TMS) | 16.47 | 255 | 300 | 19.4 |
Fig. 4 TIC of the ten CWC-related chemicals (the first group) spiked in a pump oil sample by HS-SPME and GC-MS Peak identifications: 1. pinacolyl alcohol; 2. chloropicrin; 3. dimethyl phosphite; 4. sarin; 5. 1,4-oxathiane; 6. diethyl methylphosphonate; 7. 1,4-dithiane; 8. sulfur mustard; 9. cyclopentyl methyl methylphosphonate; 10. 2-methyl-1,3,2-dithiaphosphinane 2-sulfide.
Fig. 5 TICs of CWC-related chemicals (the second group and the third group) spiked in pump oil samples by HS-SPME and GC-MS after derivatization a. the second group; b. the third group.Peak identifications: 1. EMAE (TMS); 2. MPAE (TMS); 3. quinuclidin-3-ol (TMS); 4. MDEA (2TMS); 5. EDEA (2TMS); 6. TDG (2TMS); 7. TEA (3TMS); 8. EMPA; 9. IMPA (TMS); 10. MPA (2TMS); 11. i-BuMPA (TMS); 12. PMPA (TMS); 13. CHMPA (TMS); 14. BZA (2TMS).
Fig. 6 TICs of biodiesel samples from the 38th OPCW Proficiency Test analyzed by HS-SPME-GC-MS a. Sample 385 (with 5 μg/mL dimethyl methylphosphonate), diluted 10 times with pump oil (the actual concentration for detection was 0.5 μg/mL); b. Sample 386 (with 20 μg/mL chloropicrin), diluted 10 times with pump oil (the actual concentration for detection was 2 μg/mL).Peak identifications: 1. dimethyl methylphosphonate; 2. chloropicrin.
Fig. 7 TICs of GC-MS analysis for pump oil sample 421 from the 42nd OPCW Proficiency Test using different methods a. HS-SPME method, 0.1 mL sample, sample preparation time<1 h; b. OPCW ROP method, 1 mL sample, preparation time>5 h, temperature program: 50 ℃ (2 min) to 290 ℃ (4 min) increased at 10 ℃/min, split ratio 10∶1. Divinylsulfide was not detected with OPCW ROP method.Peak identifications: 1. divinylsulfide; 2. bis(2-chloroethyl)-disulfide.
|
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 128
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 210
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||